Maxigen Biotech Inc. (TPE:1783)
Taiwan
· Delayed Price · Currency is TWD 44.00
+0.20 (0.46%)
Jul 9, 2025, 1:30 PM CST
Maxigen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 8, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 3,946 | 4,365 | 4,304 | 4,036 | 3,996 | 1,591 | Upgrade
| |
Market Cap Growth | -5.67% | 1.40% | 6.65% | 0.99% | 151.22% | -9.31% | Upgrade
|
Enterprise Value | 3,243 | 3,821 | 3,884 | 3,324 | 3,534 | 1,454 | Upgrade
|
Last Close Price | 44.00 | 48.95 | 47.35 | 44.01 | 43.58 | 19.01 | Upgrade
|
PE Ratio | 19.00 | 22.95 | 25.96 | 28.95 | 45.59 | 25.13 | Upgrade
|
Forward PE | - | 10.53 | 10.53 | 10.53 | 10.53 | 10.53 | Upgrade
|
PS Ratio | 5.40 | 6.41 | 6.92 | 6.68 | 7.81 | 3.48 | Upgrade
|
PB Ratio | 2.67 | 3.17 | 3.16 | 3.12 | 3.50 | 1.85 | Upgrade
|
P/TBV Ratio | 2.67 | 3.17 | 3.16 | 3.12 | 3.51 | 1.85 | Upgrade
|
P/FCF Ratio | 13.73 | 16.38 | 28.94 | 15.89 | 38.67 | 24.92 | Upgrade
|
P/OCF Ratio | 12.39 | 14.64 | 25.14 | 15.04 | 33.98 | 21.33 | Upgrade
|
EV/Sales Ratio | 4.44 | 5.61 | 6.24 | 5.50 | 6.90 | 3.18 | Upgrade
|
EV/EBITDA Ratio | 13.85 | 18.48 | 21.94 | 21.21 | 29.51 | 15.95 | Upgrade
|
EV/EBIT Ratio | 15.70 | 21.24 | 25.92 | 25.84 | 39.28 | 23.80 | Upgrade
|
EV/FCF Ratio | 11.28 | 14.34 | 26.11 | 13.08 | 34.20 | 22.79 | Upgrade
|
Debt / Equity Ratio | - | - | - | - | 0.01 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | - | - | - | - | 0.08 | 0.13 | Upgrade
|
Debt / FCF Ratio | - | - | - | - | 0.09 | 0.19 | Upgrade
|
Asset Turnover | 0.46 | 0.44 | 0.42 | 0.45 | 0.46 | 0.43 | Upgrade
|
Inventory Turnover | 2.76 | 2.45 | 2.46 | 2.95 | 2.98 | 2.76 | Upgrade
|
Quick Ratio | 3.76 | 3.61 | 4.02 | 5.94 | 5.53 | 3.60 | Upgrade
|
Current Ratio | 4.18 | 4.03 | 4.72 | 6.56 | 6.75 | 4.99 | Upgrade
|
Return on Equity (ROE) | 14.75% | 13.90% | 12.48% | 11.44% | 8.76% | 7.40% | Upgrade
|
Return on Assets (ROA) | 8.11% | 7.31% | 6.37% | 5.93% | 5.06% | 3.57% | Upgrade
|
Return on Capital (ROIC) | 9.12% | 8.22% | 7.05% | 6.57% | 5.56% | 3.91% | Upgrade
|
Return on Capital Employed (ROCE) | 13.90% | 13.10% | 11.00% | 9.90% | 7.80% | 7.00% | Upgrade
|
Earnings Yield | 5.29% | 4.36% | 3.85% | 3.45% | 2.19% | 3.98% | Upgrade
|
FCF Yield | 7.28% | 6.11% | 3.46% | 6.30% | 2.59% | 4.01% | Upgrade
|
Dividend Yield | 1.89% | 1.70% | 2.11% | 1.08% | - | 3.32% | Upgrade
|
Payout Ratio | 42.60% | 46.78% | 25.54% | - | 64.18% | 85.58% | Upgrade
|
Buyback Yield / Dilution | -0.96% | -0.27% | -0.07% | -5.78% | -4.81% | 8.21% | Upgrade
|
Total Shareholder Return | 0.95% | 1.42% | 2.04% | -4.70% | -4.81% | 11.53% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.